ARA290 is a synthetic 11-amino-acid research peptide modeled on a region of erythropoietin (EPO), a protein involved in red blood cell production and cellular responses to injury. ARA290 was designed to investigate tissue-protective signaling without the red blood cell–stimulating activity associated with EPO. It is studied in experimental models examining inflammatory signaling, cellular stress responses, and nerve tissue biology.
In scientific research, ARA290 is investigated for its interaction with the proposed innate repair receptor, a complex involving the erythropoietin receptor and the β-common receptor (CD131). Experimental investigations have examined its effects on neuroinflammation, nerve injury responses, cellular survival, and tissue-protection pathways. These findings remain specific to the research models and conditions studied.
Quantity: 10 mg
Form: Lyophilized Research Peptide
Research Use Only. Not for human consumption.
$29.99
In stock
At Bakersfield Aminos, we provide research materials with analytical documentation to support informed laboratory investigations. ARA290 10 mg is a synthetic research peptide studied in experimental models involving inflammatory signaling, cellular stress, peripheral nerve biology, and tissue-protection pathways.
ARA290 10 mg has been evaluated by Chromate using reverse-phase high-performance liquid chromatography with ultraviolet detection (RP-HPLC with UV detection). Report #39917, dated September 22, 2026, identifies the tested material as ARA290 and documents results for two samples:
These measurements apply to the samples analyzed in this report. Researchers should consult the Certificate of Analysis associated with their specific lot when reviewing analytical results.
ARA290 is a synthetic 11-amino-acid peptide modeled on a region of erythropoietin (EPO). It was designed to investigate tissue-protective signaling separately from the red blood cell–stimulating activity associated with EPO. This distinction makes ARA290 a subject of research into cellular responses to injury and inflammation.
ARA290 has been investigated in relation to the proposed innate repair receptor, a complex involving the erythropoietin receptor and the β-common receptor (CD131). Research examines how this signaling system participates in cellular protection and responses to tissue stress. Its biological effects depend on the experimental model and conditions used.
Preclinical investigations have examined ARA290 in models of peripheral nerve injury, neuroinflammation, and altered sensory signaling. Studies have explored changes in spinal microglial responses and other processes associated with nerve injury. These experimental findings describe areas of scientific investigation and do not establish therapeutic benefits for this research product.
ARA290 10 mg is supplied as a lyophilized research peptide. Researchers should select preparation, handling, and experimental conditions appropriate to their validated laboratory protocols. The nominal product quantity is 10 mg per vial; sample-specific measured quantities are documented in the applicable COA.
The Chromate report provides the testing method, sample quantities, purity measurements, sample receipt date, and analysis date. Report #39917 can be accessed through the product’s COA verification link using access code 88YS5M42XR3N.
Analytical purity is one aspect of material characterization. This report does not establish sterility, endotoxin status, or suitability for clinical use.
Product: ARA290 10 mg
Compound: ARA290
Compound Type: Synthetic peptide
Peptide Length: 11 amino acids
Nominal Quantity: 10 mg per vial
Physical Form: Lyophilized peptide
Research Focus: EPO-related tissue-protective signaling, proposed innate repair receptor activity, inflammatory responses, cellular stress, and nerve biology
Testing Laboratory: Chromate
Analytical Method: RP-HPLC with UV detection
Reported Identity: ARA290
Sample 1 Results: 99.408% purity; 10.29 mg
Sample 2 Results: 99.417% purity; 10.94 mg
Report Number: 39917
Sample Received: September 21, 2026
Analysis Date: September 22, 2026
Storage Conditions: Follow the product label and accompanying batch documentation. Use laboratory handling procedures appropriate for lyophilized peptides and avoid unnecessary exposure to heat, moisture, and light.
FOR RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION.
This product is supplied exclusively for laboratory research and development. It is not intended for human or veterinary administration, therapeutic applications, diagnostic procedures, cosmetic use, or other clinical applications.
ARA290 is an investigational research peptide. References to receptor activity, inflammatory signaling, nerve biology, or tissue protection describe experimental research topics and should not be interpreted as claims that this product diagnoses, treats, cures, or prevents any disease.
Handle this material only in an appropriate laboratory setting using trained personnel, suitable protective equipment, and established safety procedures. Consult available safety documentation before handling, storage, or disposal.
Researchers are responsible for selecting appropriate experimental protocols and complying with applicable requirements governing the purchase, possession, handling, storage, and use of research materials.
